최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Clinica chimica acta, v.412 no.21/22, 2011년, pp.1978 - 1982
Park, Y.S. (Division of Mass Spectrometry Research, Korea Basic Science Institute, Cheongwon, Chungbuk 363-883, Republic of Korea) , Yoo, C.W. (Division of Mass Spectrometry Research, Korea Basic Science Institute, Cheongwon, Chungbuk 363-883, Republic of Korea) , Lee, S.C. (Division of Mass Spectrometry Research, Korea Basic Science Institute, Cheongwon, Chungbuk 363-883, Republic of Korea) , Park, S.J. (Division of Mass Spectrometry Research, Korea Basic Science Institute, Cheongwon, Chungbuk 363-883, Republic of Korea) , Oh, J.H. , Yoo, B.C. , Paik, S.S. , Lee, K.G. , Jin, S.Y. , Kim, S.C. , Kim, K.P. , Kim, Y.H. , Choi, D. , Kim, H.K.
Background: We evaluated whether direct tissue matrix-assisted laser desorption/ionization (MALDI) mass spectrometry (MS) analysis of lipids may distinguish intrahepatic cholangiocarcinomas from adjacent normal tissue and from other adenocarcinomas that frequently metastasize to liver. M...
Lancet Oncol Bonney 9 149 2008 10.1016/S1470-2045(08)70027-5 Circulating markers of biliary malignancy: opportunities in proteomics?
Am J Surg Pathol Hurlimann 15 3 280 1991 10.1097/00000478-199103000-00008 Immunohistochemistry in the differential diagnosis of liver carcinomas
Proteomics Farid 2011 10.1002/pmic.201000653 Shotgun proteomics of human bile in hilar cholangiocarcinoma
Mol Cell Proteomics Dos Santos 9 9 1991 2010 10.1074/mcp.M110.000026 Identification of cellular targets in human intrahepatic cholangiocarcinoma using laser microdissection and accurate mass and time tag proteomics
Proteomics Srisomsap 4 4 1135 2004 10.1002/pmic.200300651 Proteomic analysis of cholangiocarcinoma cell line
Nat Med Stoeckli 7 493 2001 10.1038/86573 Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues
Lancet Yanagisawa 362 9382 433 2003 10.1016/S0140-6736(03)14068-8 Proteomic patterns of tumour subsets in non-small-cell lung cancer
Cancer Res Schwartz 65 17 7674 2005 10.1158/0008-5472.CAN-04-3016 Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry
J Proteome Res Kim 9 8 4123 2010 10.1021/pr100302b Gastric cancer-specific protein profile identified using endoscopic biopsy samples via MALDI mass spectrometry
J Chromatogr B Analyt Technol Biomed Life Sci Jackson 877 26 2822 2009 10.1016/j.jchromb.2008.11.033 Direct profiling of tissue lipids by MALDI-TOFMS
Anal Chem Shanta 83 4 1252 2011 10.1021/ac1029659 Binary matrix for MALDI imaging mass spectrometry of phospholipids in both ion modes
J Proteomics Meriaux 73 6 1204 2010 10.1016/j.jprot.2010.02.010 Liquid ionic matrixes for MALDI mass spectrometry imaging of lipids
Biochimie Momchilova 80 12 1055 1998 10.1016/S0300-9084(99)80012-1 Phospholipid dependence of membrane-bound phospholipase A2 in ras-transformed NIH 3T3 fibroblasts
Int J Biochem Momchilova 18 945 1986 10.1016/0020-711X(86)90076-5 Phospholipid composition modifications influence phospholipase A2 activity in rat liver plasma membranes
Cancer Res Hilvo 2011 10.1158/0008-5472.CAN-10-3894 Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression
Curr Med Chem Janardhan 13 10 1169 2006 10.2174/092986706776360923 Choline kinase: an important target for cancer
PLoS One Gallego-Ortega 4 11 e7819 2009 10.1371/journal.pone.0007819 Differential role of human choline kinase alpha and beta enzymes in lipid metabolism: implications in cancer onset and treatment
Biochem Biophys Res Commun Ramírez de Molina 296 3 580 2002 10.1016/S0006-291X(02)00920-8 Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers
Cancer Res Glunde 64 4270 2004 10.1158/0008-5472.CAN-03-3829 Molecular causes of the aberrant choline phospholipid metabolism in breast cancer
Cancer Res Iorio 65 9369 2005 10.1158/0008-5472.CAN-05-1146 Alterations of choline phospholipid metabolism in ovarian tumor progression
Arch Pathol Lab Med Park 131 10 1561 2007 10.5858/2007-131-1561-POIMHD Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.